FDA Orange Book · active-ingredient family
Venlafaxine besylate
Venlafaxine besylate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:VENLAFAXINE BESYLATE · NDA 215429
1
Brand (NDA)
0
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet, extended release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| VENLAFAXINE BESYLATERLD | ALMATICA | NDA 215429 | — | Jun 29, 2022 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7776358 | May 16, 2028 | in 1 yr 11 mo | Product |
Venlafaxine besylate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
